Damage control resuscitation: The new face of damage control

Journal of Trauma - Injury, Infection and Critical Care

Volumn 69, Issue 4, 2010, Pages 976-990

  Duchesne, Juan C ^a   McSwain, Norman E ^a   Cotton, Bryan A ^b   Hunt, John P ^c   Dellavolpe, Jeff ^a   Lafaro, Kelly ^a   Marr, Alan B ^c   Gonzalez, Earnest A ^b   Phelan, Herb A ^d   Bilski, Tracy ^e   Greiffenstein, Patrick ^c   Barbeau, James M ^c   Rennie, Kelly V ^a   Baker, Christopher C ^c   Brohi, Karim ^f   Jenkins, Donald H ^g   Rotondo, Michael ^h  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^f ROYAL LONDON HOSPITAL   (United Kingdom)

^g MAYO CLINIC   (United States)

^h EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; FRESH FROZEN PLASMA; ISOTONIC SOLUTION; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SODIUM CHLORIDE; THROMBOCYTE CONCENTRATE;

ACIDOSIS; BLEEDING; BLOOD; BLOOD CLOTTING DISORDER; BLOOD GROUP; BLOOD TRANSFUSION; CLINICAL PRACTICE; CRYOPRECIPITATE; CRYSTALLOID; DAMAGE CONTROL RESUSCITATION; FLUID RESUSCITATION; HEMOPHILIA; HUMAN; HYPOTENSION; HYPOTHERMIA; INJURY; PRIORITY JOURNAL; REVIEW; TRAUMATIC BRAIN INJURY;

ACIDOSIS; AFGHAN CAMPAIGN 2001-; BLOOD TRANSFUSION; COMBINED MODALITY THERAPY; FACTOR VIIA; FLUID THERAPY; HEMORRHAGE; HUMANS; HYPOTHERMIA; INTENSIVE CARE UNITS; IRAQ WAR, 2003 -; MILITARY PERSONNEL; MULTIPLE TRAUMA; PATIENT CARE TEAM; RECOMBINANT PROTEINS; RESUSCITATION; SHOCK, HEMORRHAGIC;

EID: 77958198424     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181f2abc9     Document Type: Review

References (148)

1. Tieu BH, Holcomb JB, Schreiber MA. Coagulopathy: its pathophysiologyand treatment in the injured patient. World J Surg. 2007;31: 1055-1064.
2. Shapiro MB, Jenkins DH, Schwab CW, Rotondo MF. Damage control: collective review. J Trauma. 2000;49: 969-978.
3. Vargo DJ, Battistella FD. Abbreviated thoracotomy and temporarychest closure: an application of damage control after thoracic trauma.Arch Surg. 2001;136: 21-24.
4. Harwood PJ, Giannoudis PV, van Griensven M, et al. Alterations in thesystemic inflammatory response after early total care and damagecontrol procedures for femoral shaft fracture in severely injured patients.J Trauma. 2005;58: 446-452; discussion 452-454.
5. Pape HC, Rixen D, Morley J, et al. Impact of the method of initialstabilization for femoral shaft fractures in patients with multiple injuriesat risk for complications (borderline patients). Ann Surg. 2007;246: 491-499; discussion 499-501.
6. Rixen D, Grass G, Sauerland S, et al. Evaluation of criteria for temporaryexternal fixation in risk-adapted damage control orthopedic surgery offemur shaft fractures in multiple trauma patients: "evidence-based medicine"versus "reality" in the trauma registry of the German TraumaSociety. J Trauma. 2005;59: 1375-1394; discussion 1394-1395.
7. Scalea TM, Boswell SA, Scott JD, et al. External fixation as a bridgeto intramedullary nailing for patients with multiple injuries and withfemur fractures: damage control orthopedics. J Trauma. 2000;48: 613-621 2000; discussion 621-623.
8. Taeger G, Ruchholtz S, Waydhas C, et al. Damage control orthopedicsin patients with multiple injuries is effective, time saving, and safe.J Trauma. 2005;59: 409-416; discussion 417.
9. Moore EE. Staged laparotomy for the hypothermia, acidosis, andcoagulopathy syndrome. Am J Surg. 1996;172: 405-410.
10. Rotondo MF, Zonies DH. The damage control sequence and underlyinglogic. Surg Clin North Am. 1997;77: 761-777.
11. Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007;62: 307-310.
12. Martini WZ, Pusateri AE, Uscilowicz JM, et al. Independent contributionsof hypothermia and acidosis to coagulopathy in swine. J Trauma.2005;58: 1002-1009; discussion 1009-1010.
13. Cannon WB, Fraser J, Cowell EM. The preventive treatment of woundshock. JAMA. 1918;70: 618.
14. Beecher HK. Surgery in World War II, General Surgery. In: Dot A, ed.Office of the Surgeon General Washington, DC: U.S. GovernmentPrinting Office; 1952: 6.
15. Bickell WH, Wall MJ, Pepe PE, et al. Immediate versus delayed fluidresuscitation for hypotensive patients with penetrating torso injuries.N Engl J Med. 1994;331: 1105-1109.
16. Wall MJ, Granchi T, Liscum K, Aucar J, Mattox K. Delayed versusimmediate fluid resuscitation in patients with penetrating trauma: subgroup analysis. J Trauma. 1995;39: 173.
17. Burris D, Rhee P, Kaufmann C, et al. Controlled resuscitation foruncontrolled hemorrhagic shock. J Trauma. 1999;46: 216-223.
18. Dutton RP, Mackenzie CF, Scalea TM. Hypotensive resuscitationduring active hemorrhage: impact on in-hospital mortality. J Trauma.2002;52: 1141-1146.
19. Silbergleit R, Satz W, McNamara RM, et al. Effect of permissivehypotension in continuous uncontrolled intra-abdominal hemorrhage.Acad Emerg Med. 1996;3: 922-926.
20. Hirshberg A, Hoyt DB, Mattox KL. Timing of fluid resuscitationshapes the hemodynamic response to uncontrolled hemorrhage: analysisusing dynamic modeling. J Trauma. 2006;60: 1221-1227.
21. Owens TM, Watson WC, Prough DS, et al. Limiting initial resuscitationof uncontrolled hemorrhage reduces internal bleeding and subsequentvolume requirements. J Trauma. 1995;39: 200-207; discussion 208-209.
22. Bruscagin V, de Figueiredo LF, Rasslan S, et al. Fluid resuscitationimproves hemodynamics without increased bleeding in a model ofuncontrolled hemorrhage induced by an iliac artery tear in dogs.J Trauma. 2002;52: 1147-1152.
23. Surgeons ACo. ATLS Guidelines. Chicago, IL: Surgeons ACo; 2007.24.
24. Kreimeier U, Lackner CK, Pruckner S, et al. [Permissive hypotensionin severe trauma.] Anaesthesist. 2002;51: 787-799.
25. Soreide E, Deakin CD. Pre-hospital fluid therapy in the criticallyinjured patient-a clinical update. Injury. 2005;36: 1001-1010.
26. Carrico CJ, Canizaro PC, Shires GT. Fluid resuscitation followinginjury: Rationale for the use of balanced salt solutions. Crit Care Med.1976;4: 46-54.
27. Bacter CR, Canizaro PC, Carrico CJ, Shires GT. Fluid resuscitation ofhemorrhagic shock. Postgrad Med. 1970;48: 95-99.
28. Pope A, Longnecker D, French G, eds. Fluid Resuscitation: State of theScience of Treating Combat Casualties and Civilian Injuries. Washington DC, Institute of Medicine, National Academic Press, 1999.
29. Cotton BA, Guy JS, Morris JA Jr, Abumrad NN. The cellular, metabolic,and systemic consequences of aggressive fluid resuscitationstrategies. Shock. 2006;26: 115-121.
30. Rhee P, Koustova E, Alam HB. Searching for the optimal resuscitationmethod: recommendations for the initial fluid resuscitation of combatcasualties. J Trauma. 2003;54(5 suppl): S52-SS.
31. Wheeler AP, Bernard GR, Thompson BT, et al. Pulmonary-arteryversus central venous catheter to guide treatment of acute lung injury.N Engl J Med. 2006;354: 2213-2224.
32. Shoemaker WC, Hauser CJ. Critique of crystalloid versus colloidtherapy in shock and shock lung. Crit Care Med. 1979;7: 117-124.
33. Attuwaybi B, Kozar RA, Gates KS, et al. Hypertonic saline preventsinflammation, injury, and impaired intestinal transit after gut ischemia/reperfusion by inducing heme oxygenase 1 enzyme. J Trauma. 2004;56: 749-758; discussion 758-759.
34. Balogh Z, McKinley BA, Cocanour CS, et al. Supranormal traumaresuscitation causes more cases of abdominal compartment syndrome.Arch Surg. 2003;138: 637-642; discussion 642-643.
35. Velasco IT, Pontieri V, Rocha e Silva M Jr, Lopes OU. HyperosmoticNaCl and severe hemorrhagic shock. Am J Physiol. 1980;239: H664-HH.
36. Mazzoni MC, Borgstrom P, Arfors KE, Intaglietta M. Dynamic fluidredistribution in hyperosmotic resuscitation of hypovolemic hemorrhage.Am J Physiol. 1988;255(3 Pt 2): H629-HH.
37. Deree J, Martins JO, Leedom A, et al. Hypertonic saline andpentoxifylline reduces hemorrhagic shock resuscitation-inducedpulmonary inflammation through attenuation of neutrophil degranulationand proinflammatory mediator synthesis. J Trauma. 2007;62: 104-111.
38. Deree J, de Campos T, Shenvi E, et al. Hypertonic saline and pentoxifyllineattenuates gut injury after hemorrhagic shock: the kinder, gentlerresuscitation. J Trauma. 2007;62: 818-827; discussion 827-828.
39. Rizoli SB, Rhind SG, Shek PN, et al. The immunomodulatory effectsof hypertonic saline resuscitation in patients sustaining traumatic hemorrhagicshock: a randomized, controlled, double-blinded trial. AnnSurg. 2006;243: 47-57.
40. Bulger EM, Cuschieri J, Warner K, Maier RV. Hypertonic resuscitationmodulates the inflammatory response in patients with traumatic hemorrhagicshock. Ann Surg. 2007;245: 635-641.
41. Rotstein OD. Novel strategies for immunomodulation after trauma: revisiting hypertonic saline as a resuscitation strategy for hemorrhagicshock. J Trauma. 2000;49: 580-583.
42. Shackford SR, Bourguingnon PR, Wald SL, et al. Hypertonic salineresuscitation of patients with head injury: a prospective, randomizedclinical trial. J Trauma. 1998;44: 50-58.
43. Simma B, Burger R, Falk M, Sacher P, Fanconi S. A prospective,randomized, and controlled study of fluid management in children withsevere head injury: lactated Ringer's solution versus hypertonic saline.Crit Care Med. 1998;26: 1265-1270.
44. Catrambone JE, He W, Prestigiacomo CJ, McIntosh TK, Carmel PW,Maniker A. The use of hypertonic saline in the treatment of posttraumaticcerebral edema: a review. Eur J Trauma Emerg Surg.2007;34: 397-409.
45. Mattox KL, Maningas PA, Moore EE, et al. Prehospital hypertonicsaline/ dextran infusion for post-traumatic hypotension. The U.S.A.Multicenter Trial. Ann Surg. 1991;213: 482-491.
46. Wade CE, Kramer GC, Grady JJ, et al. Efficacy of hypertonic 7.5%saline and 6% dextran-70 in treating trauma: a meta-analysis of controlledclinical studies. Surgery. 1997;122: 609-616.
47. Doyle JA, Davis DP, Hoyt DB. The use of hypertonic saline in thetreatment of traumatic brain injury. J Trauma. 2001;50: 367-383.
48. Dubick MA, Bruttig SP, Wade CE. Issues of concern regarding the useof hypertonic/hyperoncotic fluid resuscitation of hemorrhagic hypotension.Shock. 2006;25: 321-328.
49. Luna GK, Maier RV, Pavlin EG, et al. Incidence and effect ofhypothermia in seriously injured patients. J Trauma. 1987;27: 1014-1018.
50. Slotman GJ, Jed EH, Burchard KW. Adverse effects of hypothermia inpostoperative patients. Am J Surg. 1985;149: 495-501.
51. Sebesta J. Special lessons learned from Iraq. Surg Clin North Am.2006;86: 711-726.
52. Tsuei BJ, Kearney PA. Hypothermia in the trauma patient. Injury.2004;35: 7-15.
53. Jurkovich GJ, Greiser WB, Luterman A, Curreri PW. Hypothermia intrauma victims: an ominous predictor of survival. J Trauma. 1987;27: 1019-1024.
54. Hirshberg A, Sheffer N, Barnea O. Computer simulation of hypothermiaduring "damage control" laparotomy. World J Surg. 1999;23: 960-965.
55. Burch JM, Denton JR, Noble RD. Physiologic rationale for abbreviatedlaparotomy. Surg Clin North Am. 1997;77: 779-782.
56. Ho AM, Karmakar MK, Dion PW. Are we giving enough coagulationfactors during major trauma resuscitation? Am J Surg. 2005;190: 479-484.
57. Watts DD, Trask A, Soeken K, et al. Hypothermic coagulopathy intrauma: effect of varying levels of hypothermia on enzyme speed,platelet function, and fibrinolytic activity. J Trauma. 1998;44: 846-854.
58. Krause KR, Amuzescu B, Krause U, et al. Hypothermia-inducedcoagulopathy during hemorrhagic shock. Am Surg. 2000;66: 348-354.
59. Heinius G, Wladis A, Hahn RG, Kjellstrom BT. Induced hypothermiaand rewarming after hemorrhagic shock J Surg Res. 2002;108: 7-13.
60. Fildes J, Sheaff C, Barrett J. Very hot intravenous fluid in the treatmentof hypothermia. J Trauma. 1993;35: 683-686; discussion 686-687.
61. Gentilello LM, Cobean RA, Offner PJ, et al. Continuous arteriovenousrewarming: rapid reversal of hypothermia in critically ill patients.J Trauma. 1992;32: 316-325; discussion 325-327.
62. Gentilello LM, Rifley WJ. Continuous arteriovenous rewarming: reportof a new technique for treating hypothermia. J Trauma. 1991;31: 1151-1154.
63. Mikhail J. The trauma triad of death: hypothermia, acidosis, andcoagulopathy. AACN Clin Issues. 1999;10: 85-94.
64. Meng ZH, Wolberg AS, Monroe DM III, et al. The effect of temperatureand pH on the activity of factor VIIa: implications for the efficacyof high-dose factor VIIa in hypothermic and acidotic patients.J Trauma. 2003;55: 886-891.
65. Cosgriff N, Moore EE, Sauaia A, et al. Predicting life- threateningcoagulopathy in the massively transfused trauma patient: hypothermiaand acidoses revisited. J Trauma. 1997;42: 857-861; discussion 861-862.
66. Bannon MP, O'Neill CM, Martin M, et al. Central venous oxygensaturation, arterial base deficit, and lactate concentration in traumapatients. Am Surg. 1995;61: 738-745.
67. Davis JW, Kaups KL, Parks SN. Base deficit is superior to pH inevaluating clearance of acidosis after traumatic shock. J Trauma.1998;44: 114-118.
68. Rutherford EJ, Morris JA Jr, Reed GW, Hall KS. Base deficit stratifiesmortality and determines therapy. J Trauma. 1992;33: 417-423.
69. Abramson D, Scalea TM, Hitchcock R, et al. Lactate clearance andsurvival following injury. J Trauma. 1993;35: 584-588; discussion 588-589.
70. Husain FA, Martin MJ, Mullenix PS, et al. Serum lactate and basedeficit as predictors of mortality and morbidity. Am J Surg. 2003;185: 485-491.
71. Jeng JC, Jablonski K, Bridgeman A, Jordan MH. Serum lactate, notbase deficit, rapidly predicts survival after major burns. Burns. 2002;28: 161-166.
72. Manikis P, Jankowski S, Zhang H, et al. Correlation of serial bloodlactate levels to organ failure and mortality after trauma. Am J EmergMed. 1995;13: 619-622.
73. McNelis J, Marini CP, Jurkiewicz A, et al. Predictive factors associatedwith the development of abdominal compartment syndrome in thesurgical intensive care unit. Arch Surg. 2002;137: 133-136.
74. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy.J Trauma. 2003;54: 1127-1130.
75. MacLeod JB, Lynn M, McKenney MG, et al. Early coagulopathypredicts mortality in trauma. J Trauma. 2003;55: 39-44.
76. May AK, Young JS, Butler K, et al. Coagulopathy in severe closedhead injury: is empiric therapy warranted? Am Surg. 1997;63: 233-236;discussion 236-237.
77. Faringer PD, Mullins RJ, Johnson RL, Trunkey DD. Blood componentsupplementation during massive transfusion of AS-1 red cells in traumapatients. J Trauma. 1993;34: 481-485; discussion 485-487.
78. Patt A, McCroskey BL, Moore EE. Hypothermia-induced coagulopathiesin trauma. Surg Clin North Am. 1988;68: 775-785.
79. MacLeod JB. Trauma and coagulopathy. A new paradigm to consider.Arch Surg. 2008;143: 797-801.
80. Lier H, Krep H, Schroeder S, et al. Preconditions of hemostasis intrauma: a review. The influence of acidosis, hypocalcemia, anemia, andhypothermia on functional hemostasis in trauma. J Trauma. 2008;65: 951-960.
81. Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: areview of mechanisms. J Trauma. 2008;65: 748-754.
82. Spahn DR, Rossaint R. Coagulopathy and blood component transfusionin trauma. Br J Anaesth. 2005;95: 130-139.
83. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of bloodproducts transfused affects mortality in patients receiving massivetransfusions at a combat support hospital. J Trauma. 2007;63: 805-813.
84. Ketchum L, Hess JR, Hiippala S. Indications for early fresh frozenplasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma.2006;60(6 suppl): S51-SS.
85. Malone DL, Hess JR, Fingerhut A. Massive transfusion practicesaround the globe and a suggestion for a common massive transfusionprotocol. J Trauma. 2006;60(6 suppl): S91-SS.
86. Hirshberg A, Dugas M, Banez EI, et al. Minimizing dilutional coagulopathyin exsanguinating hemorrhage: a computer simulation.J Trauma. 2003;54: 454-463.
87. Cocchi MN, Kimlin E, Walsh M, Donnino MW. Identification andresuscitation of the trauma patient in shock. Emerg Med Clin North Am.2007; 25: 623-642, vii.
88. Nunez TC, Voskresensky IV, Dossett LA, et al. Early prediction ofmassive transfusion in trauma: Simple as ABC (assessment of bloodconsumption)? J Trauma. 2009;66: 346-352.
89. Aucar JA, Norman P, Whitten E, et al. Intraoperative detection oftraumatic coagulopathy using the activated coagulation time. Shock.2003;19: 404-407.
90. Essell JH, Martin TJ, Salinas J, et al. Comparison of thromboelastographyto bleeding time and standard coagulation tests in patients after cardiopulmonarybypass. J Cardiothorac Vasc Anesth. 1993;7: 410-415.
91. Schreiber MA, Differding J, Thorborg P, et al. Hypercoagulability ismost prevalent early after injury and in female patients. J Trauma.2005;58: 475-480; discussion 480-481.
92. Shore-Lesserson L, Manspeizer HE, DePerio M, et al. Thromboelastography- guided transfusion algorithm reduces transfusions in complexcardiac surgery. Anesth Analg. 1999;88: 312-319.
93. Schreiber MA. Coagulopathy in the trauma patient. Curr Opin CritCare. 2005;11: 590-597.
94. Traverso CI, Caprini JA, Arcelus JI. The normal thromboelastogramand its interpretation. Semin Thromb Hemost. 1995;21(suppl 4): 7-13.
95. Spiess BD, Gillies BS, Chandler W, Verrier E. Changes in transfusiontherapy and reexploration rate after institution of a blood managementprogram in cardiac surgical patients. J Cardiothorac Vasc Anesth.1995;9: 168-173.
96. Mongan PD, Hosking MP. The role of desmopressin acetate in patientsundergoing coronary artery bypass surgery. A controlled clinical trialwith thromboelastographic risk stratification. Anesthesiology. 1992;77: 38-46.
97. Royston D, von Kier S. Reduced haemostatic factor transfusion usingheparinase-modified thrombelastography during cardiopulmonary bypass.Br J Anaesth. 2001;86: 575-578.
98. Hess JR, Lawson JH. The coagulopathy of trauma versus disseminatedintravascular coagulation. J Trauma. 2006;60(6 suppl): S12-SS.
99. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma. 1995;38: 185-193.
100. Hewson JR, Neame PB, Kumar N, et al. Coagulopathy related todilution and hypotension during massive transfusion. Crit Care Med.1985;13: 387-391.
101. Duchesne JC, Hunt JP, Wahl G, et al. Review of current bloodtransfusions strategies in a mature level I trauma center: were we wrongfor the last 60 years? J Trauma. 2008;65: 272-276; discussion 276-278.
102. Gonzalez EA, Moore FA, Holcomb JB, et al. Fresh frozen plasmashould be given earlier to patients requiring massive transfusion.J Trauma. 2007;62: 112-119.
103. Ho AM, Dion PW, Cheng CA, et al. A mathematical model for freshfrozen plasma transfusion strategies during major trauma resuscitationwith ongoing hemorrhage. Can J Surg. 2005;48: 470-478.
104. Biffl WL, Smith WR, Moore EE, et al. Evolution of a multidisciplinaryclinical pathway for the management of unstable patients with pelvicfractures. Ann Surg. 2001;233: 843-850.
105. Vaslef SN, Knudsen NW, Neligan PJ, Sebastian MW. Massive transfusionexceeding 50 units of blood products in trauma patients.J Trauma. 2002;53: 291-295; discussion 295-296.
106. Downes KA, Wilson E, Yomtovian R, Sarode R. Serial measurementof clotting factors in thawed plasma stored for 5 days. Transfusion.2001;41: 570.
107. Smak Gregoor PJ, Harvey MS, Briet E, Brand A. Coagulation parametersof CPD fresh-frozen plasma and CPD cryoprecipitate-poorplasma after storage at 4 degrees C for 28 days. Transfusion. 1993;33: 735-738.
108. Kauvar DS, Holcomb JB, Norris GC, Hess JR. Fresh whole bloodtransfusion: a controversial military practice. J Trauma. 2006;61: 181-184.
109. Sihler KC, Napolitano LM. Complications of massive transfusion.C hest. 2010;137: 209-220.
110. Mohr R, Martinowitz U, Lavee J, et al. The hemostatic effect oftransfusing fresh whole blood versus platelet concentrates after cardiacoperations. J Thorac Cardiovasc Surg. 1988;96: 530-534.
111. Malone DL, Dunne J, Tracy JK, et al. Blood transfusion, independentof shock severity, is associated with worse outcome in trauma
112. Moore FA, Moore EE, Sauaia A. Blood transfusion. An independentrisk factor for postinjury multiple organ failure. Arch Surg. 1997;132: 620-624; discussion 624-625.
113. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acutelung injury. Blood. 2005;105: 2266-2273.
114. Marik PE, Corwin HL. Acute lung injury following blood transfusion: expanding the definition Crit Care Med 2008;36: 3080-3084.
115. Moore FA, McKinley BA, Moore EE. The next generation in shockresuscitation. Lancet. 2004;363: 1988-1996.
116. Claridge JA, Sawyer RG, Schulman AM, et al. Blood transfusionscorrelate with infections in trauma patients in a dose-dependent manner.A m Surg. 2002;68: 566-572.
117. Gunter OL, Au BK, Isbell JM, et al. Optimizing outcomes in damagecontrol resuscitation: identifying blood product ratios associated withimproved survival. J Trauma. 2008;65: 527-534.
118. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma andplatelet to red blood cell ratios improves outcome in 466 massivelytransfused civilian trauma patients. Ann Surg. 2008;248: 447-458.
119. Schreiber MA, Perkins J, Kiraly L, et al. Early predictors of massivetransfusion in combat casualties. J Am Coll Surg. 2007;205: 541-545.
120. Hudson LD, Milberg JA, Anardi D, Maunder RJ. Clinical risks fordevelopment of the acute respiratory distress syndrome. Am J RespirCrit Care Med. 1995;151(2 Pt 1): 293-301.
121. Khan H, Belsher J, Yilmaz M, et al. Fresh-frozen plasma and platelettransfusions are associated with development of acute lung injury incritically ill medical patients. Chest. 2007;131: 1308-1314.
122. Silliman CC, McLaughlin NJ. Transfusion-related acute lung injury.B lood Rev. 2006;20: 139-159.
123. Aiboshi J, Moore EE, Ciesla DJ, Silliman CC. Blood transfusion andthe two-insult model of post-injury multiple organ failure. Shock.2001;15: 302-306.
124. Hess JR, Zimrin AB. Massive blood transfusion for trauma. Curr OpinHematol. 2005;12: 488-492.
125. Cohen M, Brohi K, Ganter M, et al. Early coagulopathy after traumaticbrain injury: the role of hypoperfusion and the protein C pathway
126. Al-Ruzzeh S, Navia JL. The "off-label" role of recombinant factor VIIain surgery: Is the problem deficient evidence or defective concept?J Am Coll Surg. 2009;209: 659-667.
127. AABB. Standards for Blood Banks and Transfusion Services. 25th ed.Vol. 35. Bethesda, MD: AABB; 2008.128.
128. Kushner I. The phenomenon of the acute phase response. Ann N Y AcadSci. 1982;389: 39-48.
129. Lane DA, Scully MF, Thomas DP, et al. Acquired dysfibrinogenaemiain acute and chronic liver disease. Br J Haematol. 1977;35: 301-308.
130. Holcomb JB. Damage control resuscitation. J Trauma. 2007;62(6suppl): S36-SS.
131. Franchini M, Lippi G, Guidi GC. The use of recombinant activatedfactor VII in platelet-associated bleeding. Hematology. 2008;13: 41-45.
132. Martinowitz U, Kenet G, Segal E, et al. Recombinant activated factorVII for adjunctive hemorrhage control in trauma. J Trauma. 2001;51: 431-438; discussion 438-439.
133. Khan AZ, Parry JM, Crowley WF, et al. Recombinant factor VIIa forthe treatment of severe postoperative and traumatic hemorrhage. Am JSurg. 2005;189: 331-334.
134. Benharash P, Bongard F, Putnam B. Use of recombinant factor VIIa foradjunctive hemorrhage control in trauma and surgical patients. AmSurg. 2005;71: 776-780.
135. Schreiber MA, Holcomb JB, Rojkjaer R. Preclinical trauma studies ofrecombinant factor VIIa. Crit Care 2005; 9 Suppl 5: S25-SS.
136. Dutton RP, Hess JR, Scalea TM. Recombinant factor VIIa for controlof hemorrhage: early experience in critically ill trauma patients. J ClinAnesth. 2003;15: 184-188.
137. Boffard KD, Riou B, Warren B, et al. Recombinant factor VIIa asadjunctive therapy for bleeding control in severely injured traumapatients: two parallel randomized, placebo-controlled, double-blindclinical trials. J Trauma. 2005;59: 8-15; discussion 15-18.
138. Raobaikady R, Redman J, Ball JA, Maloney G, Grounds RM. Use ofactivated recombinant coagulation factor VII in patients undergoingreconstruction surgery for traumatic fracture of pelvis or pelvis andacetabulum: a double-blind, randomized, placebo-controlled trial. Br JAnaesth. 2005;94: 586-591.
139. Perkins JG, Schreiber MA, Wade CE, Holcomb JB. Early versus laterecombinant factor VIIa in combat trauma patients requiring massivetransfusion. J Trauma. 2007;62: 1095-1099; discussion 1099-1101.
140. Stein DM, Dutton RP, O'Connor J, et al. Determinants of futility ofadministration of recombinant factor VIIa in trauma. J Trauma. 2005;59: 609-615.
141. Duchesne JC, Mathew KA, Marr AB, Pinsky MR, Barbeau JM,McSwain NE. Current evidence based guidelines for factor viia use intrauma: the good, the bad and the ugly. Am Surg. 2008;74: 1159-1165.
142. Feliciano DV, Burch JM, Spjut-Patrinely V, et al. Abdominal gunshotwounds. An urban trauma center's experience with 300 consecutivepatients. Ann Surg. 1988;208: 362-370.
143. Lee JC, Peitzman AB. Damage-control laparotomy. Curr Opin CritCare. 2006;12: 346-350.
144. Kouraklis G, Spirakos S, Glinavou A. Damage control surgery: analternative approach for the management of critically injured patients.Surg Today. 2002;32: 195-202.
145. Rotondo MF, Bard MR. Damage control surgery for thoracic injuries.Injury. 2004;35: 649-654.
146. Sagraves SG, Toschlog EA, Rotondo MF. Damage control surgery- theintensivist's role. J Intensive Care Med. 2006;21: 5-16.
147. Johnson JW, Gracias VH, Schwab CW, et al. Evolution in damagecontrol for exsanguinating penetrating abdominal injury. J Trauma.2001;51: 261-269; discussion 269-271.
148. Sugrue M, D'Amours SK, Joshipura M. Damage control surgery andthe abdomen. Injury. 2004;35: 642-648.